285 related articles for article (PubMed ID: 11356899)
1. Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing.
Fendt M
J Neurosci; 2001 Jun; 21(11):4111-5. PubMed ID: 11356899
[TBL] [Abstract][Full Text] [Related]
2. Amygdalar nmda receptors are critical for the expression of multiple conditioned fear responses.
Lee HJ; Choi JS; Brown TH; Kim JJ
J Neurosci; 2001 Jun; 21(11):4116-24. PubMed ID: 11356900
[TBL] [Abstract][Full Text] [Related]
3. N-Methyl-D-aspartate receptor antagonism blocks contextual fear conditioning and differentially regulates early growth response-1 messenger RNA expression in the amygdala: implications for a functional amygdaloid circuit of fear.
Malkani S; Rosen JB
Neuroscience; 2001; 102(4):853-61. PubMed ID: 11182248
[TBL] [Abstract][Full Text] [Related]
4. Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning.
Rodrigues SM; Schafe GE; LeDoux JE
J Neurosci; 2001 Sep; 21(17):6889-96. PubMed ID: 11517276
[TBL] [Abstract][Full Text] [Related]
5. Extended fear conditioning reveals a role for both N-methyl-D-aspartic acid and non-N-methyl-D-aspartic acid receptors in the amygdala in the acquisition of conditioned fear.
Pistell PJ; Falls WA
Neuroscience; 2008 Sep; 155(4):1011-20. PubMed ID: 18675886
[TBL] [Abstract][Full Text] [Related]
6. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.
Walker DL; Paschall GY; Davis M
Learn Mem; 2005; 12(2):120-9. PubMed ID: 15774945
[TBL] [Abstract][Full Text] [Related]
7. Visual pathways involved in fear conditioning measured with fear-potentiated startle: behavioral and anatomic studies.
Shi C; Davis M
J Neurosci; 2001 Dec; 21(24):9844-55. PubMed ID: 11739592
[TBL] [Abstract][Full Text] [Related]
8. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
Walker DL; Ressler KJ; Lu KT; Davis M
J Neurosci; 2002 Mar; 22(6):2343-51. PubMed ID: 11896173
[TBL] [Abstract][Full Text] [Related]
9. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala.
Falls WA; Miserendino MJ; Davis M
J Neurosci; 1992 Mar; 12(3):854-63. PubMed ID: 1347562
[TBL] [Abstract][Full Text] [Related]
10. Blockade of NMDA receptors in the amygdala prevents latent inhibition of fear-conditioning.
Schauz C; Koch M
Learn Mem; 2000; 7(6):393-9. PubMed ID: 11112798
[TBL] [Abstract][Full Text] [Related]
11. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.
Campeau S; Miserendino MJ; Davis M
Behav Neurosci; 1992 Jun; 106(3):569-574. PubMed ID: 1352104
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis of fear-potentiated startle.
Davis M
Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
[TBL] [Abstract][Full Text] [Related]
13. NMDA receptors in the pontine brainstem are necessary for fear potentiation of the startle response.
Fendt M; Koch M; Schnitzler HU
Eur J Pharmacol; 1996 Dec; 318(1):1-6. PubMed ID: 9007504
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats.
Zimmerman JM; Maren S
Eur J Neurosci; 2010 May; 31(9):1664-70. PubMed ID: 20525079
[TBL] [Abstract][Full Text] [Related]
15. NMDA currents and receptor protein are downregulated in the amygdala during maintenance of fear memory.
Zinebi F; Xie J; Liu J; Russell RT; Gallagher JP; McKernan MG; Shinnick-Gallagher P
J Neurosci; 2003 Nov; 23(32):10283-91. PubMed ID: 14614087
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala.
Fanselow MS; Kim JJ
Behav Neurosci; 1994 Feb; 108(1):210-2. PubMed ID: 7910746
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli.
Campeau S; Davis M
J Neurosci; 1995 Mar; 15(3 Pt 2):2301-11. PubMed ID: 7891168
[TBL] [Abstract][Full Text] [Related]
18. Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats.
Yang YL; Chao PK; Ro LS; Wo YY; Lu KT
Neuropsychopharmacology; 2007 May; 32(5):1042-51. PubMed ID: 17047672
[TBL] [Abstract][Full Text] [Related]
19. Intra-amygdala injections of neuropeptide S block fear-potentiated startle.
Fendt M; Imobersteg S; Bürki H; McAllister KH; Sailer AW
Neurosci Lett; 2010 May; 474(3):154-157. PubMed ID: 20298749
[TBL] [Abstract][Full Text] [Related]
20. Second-order fear conditioning prevented by blocking NMDA receptors in amygdala.
Gewirtz JC; Davis M
Nature; 1997 Jul; 388(6641):471-4. PubMed ID: 9242405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
